Clorazepic Acid

CHEMBL1213252 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

314.7 g/mol

LogP

3.3

Phase

4

A benzodiazepine-related compound that acts on the central nervous system to produce calming effects. It is used to treat anxiety disorders and may also help manage withdrawal symptoms.

Moleküler Ağırlık

314,7200 g/mol

LogP

3,30

TPSA

78,80 Å²

Lipinski RO5

Geçer

Etki Mekanizması

Enhances the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors by binding to an allosteric site and increasing the frequency of chloride ion channel opening. This produces anxiolytic, sedative, hypnotic, and anticonvulsant effects.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Enhances the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors by binding to an allosteric site and increasing the frequency of chloride ion channel opening. This produces anxiolytic, sedative, hypnotic, …

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O

InChI

InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)

Molecular Formula

C16H11ClN2O3

HBD / HBA

2 / 4

Döndürülebilir Bağlar

2

Ağır Atomlar

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A benzodiazepine-related compound that acts on the central nervous system to produce calming effects. It is used to treat anxiety disorders and may also help manage withdrawal symptoms.

Enhances the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors by binding to an allosteric site and increasing the frequency of chloride ion channel opening. This produces anxiolytic, sedative, hypnotic, and anticonvulsant effects.

Yes, Clorazepic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1213252. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 2809. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Clorazepic Acid PillFYI'da

Yapı

Hızlı Veriler

Formül: C16H11ClN2O3

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.